Coronavirus may impact India's March quarter GDP growth by 0.20% after epidemic hits imports from China for crucial sectors: Report

The brokerage cut its fiscal 2020-21 real GDP growth estimate marginally to 5.6% as against the previous estimate of 5.7%, but added that there will be a recovery in the next financial year.

Press Trust of India March 02, 2020 19:10:15 IST
Coronavirus may impact India's March quarter GDP growth by 0.20% after epidemic hits imports from China for crucial sectors: Report
  • UBS Securities said sectors such as electronics, pharmaceuticals and automobiles can see supply disruptions in value chain, which may lead to a derailment of the domestic economic growth

  • The brokerage also cut its fiscal 2020-21 real GDP growth estimate marginally to 5.6% as against the previous estimate of 5.7%

  • It warned that a delay in strengthening the balance sheet of the financial sector and weak credit impulse could continue to be a drag on the growth

Mumbai: The coronavirus epidemic can impact India's March quarter GDP growth by 0.20 percent as imports from China for crucial sectors have got affected, a foreign brokerage said on Monday.

The country's economic growth is already sagging and is set to slide to a decadal low of 5 percent in 2019-20 as per official estimates. Data for the December 2019 quarter released last week said growth had slid to a seven-year low of 4.7 percent.

Two cases tested positive for the coronavirus infection in India on Monday, after the initial set of three cases in Kerala were successfully treated.

Coronavirus may impact Indias March quarter GDP growth by 020 after epidemic hits imports from China for crucial sectors Report

Representational image. Reuters.

In a report, UBS Securities said sectors such as electronics, pharmaceuticals and automobiles can see supply disruptions in value chain, which may lead to a derailment of the domestic economic growth.

"While the situation is still evolving and the scale of economic impact is highly uncertain at this point, we think an adverse impact of 0.20 percent could be felt in India's real Gross Domestic Product (GDP) growth for the March 20 quarter," it said.

The brokerage also cut its fiscal 2020-21 real GDP growth estimate marginally to 5.6 percent as against the previous estimate of 5.7 percent, but added that there will be a recovery in the next financial year.

A favourable base effect due to FY20's low growth, improved monetary transmission and support from government spending will aid the growth momentum in the next fiscal, it said.

It warned that a delay in strengthening the balance sheet of the financial sector (banks and non-banking financial sectors) and weak credit impulse could continue to be a "drag" on the growth.

The Reserve Bank of India (RBI) is expected to cut rates by 0.25 percentage points in the next fiscal and policymakers may continue to rely on "creative measures" like the liquidity moves in the last policy review to boost the growth, it said.

Updated Date:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

BJP's Ashok Gasti dies of COVID-19; newly-elected Rajya Sabha member breathes his last at Bengaluru hospital
India

BJP's Ashok Gasti dies of COVID-19; newly-elected Rajya Sabha member breathes his last at Bengaluru hospital

Condoling Gasti's demise, Prime Minister Narendra Modi said he was passionate about empowering the poor and marginalised sections of society

India reports over 1 lakh COVID recoveries in 24 hrs; PM to hold meet with CMs of seven worst-hit states today
India

India reports over 1 lakh COVID recoveries in 24 hrs; PM to hold meet with CMs of seven worst-hit states today

The government data also revealed that at 19.5 percent, India has highest share in global Covid-19 recoveries.

Highly effective coronavirus antibodies identified, may lead to passive COVID-19 vaccine
Health

Highly effective coronavirus antibodies identified, may lead to passive COVID-19 vaccine

The research, published in the journal Cell, also shows that some SARS-CoV-2 antibodies bind to tissue samples from various organs, which could potentially trigger undesired side effects